Musashi Study Investigators. Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis - Ogata, A; Tanimura, K; Sugimoto, T (Arthritis Care Res (Hoboken), 2014)
et al.